Trial Details

COMPLETED
Basic Information
Clinical ID c3725
Identifier NCT01624376
Trial Title Randomized, Double-blind, Placebo-controlled Study in Patients With Fistulizing Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Fistulizing Crohn's Disease
Interventions DRUG: DLX105|DRUG: Placebo
Participant Information
Sponsor Delenex Therapeutics AG
City Zurich
Country/Region Switzerland
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2012-06
Primary Completion Date 2013-02
Completion Date 2013-08